Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction

Biochemical and Biophysical Research Communications

Volumn 403, Issue 3-4, 2010, Pages 452-456

  Adenuga, David ^a   Caito, Samuel ^a   Yao, Hongwei ^a   Sundar, Isaac K ^a   Hwang, Jae Woong ^a   Chung, Sangwoon ^a   Rahman, Irfan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Cigarette smoke; Inflammation; Nrf2; Oxidant

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT; STEROID; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG RESPONSE; ENZYME DEFICIENCY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; REDUCTION; WILD TYPE;

ANIMALS; BUDESONIDE; DRUG RESISTANCE; GLUCOCORTICOIDS; HISTONE DEACETYLASE 2; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; PNEUMONIA;

EID: 78650176368     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.054     Document Type: Article

References (27)

1. Keatings V.M., Jatakanon A., Worsdell Y.M., Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 1997, 155:542-548.
2. Hew M., Bhavsar P., Torrego A., Meah S., Khorasani N., Barnes P.J., Adcock I., Chung K.F. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am. J. Respir. Crit. Care Med. 2006, 174:134-141.
3. Rahman I., Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 2006, 28:219-242.
4. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell Biol. 2000, 20:6891-6903.
5. Barnes P.J., Adcock I.M. Glucocorticoid resistance in inflammatory diseases. Lancet 2009, 373:1905-1917.
6. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
7. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 2004, 36:1199-1207.
8. Goven D., Boutten A., Lecon-Malas V., Marchal-Somme J., Amara N., Crestani B., Fournier M., Leseche G., Soler P., Boczkowski J., Bonay M. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax 2008, 63:916-924.
9. Malhotra D., Thimmulappa R., Navas-Acien A., Sandford A., Elliott M., Singh A., Chen L., Zhuang X., Hogg J., Pare P., Tuder R.M., Biswal S. Decline in Nrf2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator DJ-1. Am. J. Respir. Crit. Care Med. 2008, 178:592-604.
10. Garbin U., Fratta Pasini A., Stranieri C., Cominacini M., Pasini A., Manfro S., Lugoboni F., Mozzini C., Guidi G., Faccini G., Cominacini L. Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation. PLoS One 2009, 4:e8225-e8236.
11. Harju T., Kaarteenaho-Wiik R., Soini Y., Sormunen R., Kinnula V.L. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. Am. J. Respir. Crit Care Med. 2002, 166:754-759.
12. Tomaki M., Sugiura H., Koarai A., Komaki Y., Akita T., Matsumoto T., Nakanishi A., Ogawa H., Hattori T., Ichinose M. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulm. Pharmacol. Ther. 2007, 20:596-605.
13. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., Yamamoto M., Petrache I., Tuder R.M., Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 2004, 114:1248-1259.
14. Trivedi C.M., Luo Y., Yin Z., Zhang M., Zhu W., Wang T., Floss T., Goettlicher M., Noppinger P.R., Wurst W., Ferrari V.A., Abrams C.S., Gruber P.J., Epstein J.A. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 2007, 13:324-331.
15. Yang S.R., Valvo S., Yao H., Kode A., Rajendrasozhan S., Edirisinghe I., Caito S., Adenuga D., Henry R., Fromm G., Maggirwar S., Li J.D., Bulger M., Rahman I. IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am. J. Respir. Cell Mol. Biol. 2008, 38:689-698.
16. Yao H., Edirisinghe I., Rajendrasozhan S., Yang S.R., Caito S., Adenuga D., Rahman I. Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 294:L1174-1186.
17. Yao H., Yang S.R., Edirisinghe I., Rajendrasozhan S., Caito S., Adenuga D., O'Reilly M.A., Rahman I. Disruption of p21 attenuates lung inflammation induced by cigarette smoke LPS and fMLP in mice. Am. J. Respir. Cell Mol. Biol. 2008, 39:7-18.
18. Southam D.S., Ellis R., Wattie J., Young S., Inman M.D. Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice. Eur. Respir. J. 2008, 32:970-978.
19. Adenuga D., Yao H., March T.H., Seagrave J., Rahman I. Histone deacetylase 2 is phosphorylated ubiquitinated and degraded by cigarette smoke. Am. J. Respir. Cell Mol. Biol. 2009, 40:464-473.
20. Marwick J.A., Kirkham P.A., Stevenson C.S., Danahay H., Giddings J., Butler K., Donaldson K., MacNee W., Rahman I. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am. J. Respir. Cell Mol. Biol. 2004, 31:633-642.
21. Yang S.R., Chida A.S., Bauter M.R., Shafiq N., Seweryniak K., Maggirwar S.B., Kilty I., Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am. J. Physiol. Lung. Cell Mol. Physiol. 2006, 291:L46-57.
22. Adenuga D., Rahman I. Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes. Arch. Biochem. Biophys. 2010, 498:62-73.
23. Ito K., Lim S., Caramori G., Chung K.F., Barnes P.J., Adcock I.M. Cigarette smoking reduces histone deacetylase 2 expression enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. FASEB J. 2001, 15:1110-1112.
24. Zimmermann S., Kiefer F., Prudenziati M., Spiller C., Hansen J., Floss T., Wurst W., Minucci S., Gottlicher M. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 2007, 67:9047-9054.
25. Kramer O.H. HDAC2: a critical factor in health and disease. Trends Pharmacol. Sci. 2009, 30:647-655.
26. Liu G.H., Qu J., Shen X. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim. Biophys. Acta 2008, 1783:713-727.
27. Sun Z., Chin Y.E., Zhang D.D. Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol. Cell Biol. 2009, 29:2658-2672.